NewLeaf Symbiotics Closes $45M Series D
Summary
Agricultural biotech leader NewLeaf Symbiotics (NewLeaf) has closed a fully funded $45 million Series D led by new investor Gullsp\xe5ng Re:food, with participation from Otter Capital Partners LP, S2G Ventures, Leaps by Bayer and other unnamed backers.NewLeaf is a pioneer and global leader in pink-pigmented facultative methylotrophs (PPFMs). Basically, they are members of the Methylobacterium family of bacteria that are commonly found in soil, on plant surfaces, in some fresh waters, and in dust. This is up from a value of $13.35 billion in 2023 to $33.69 billion by 2030, according to Fortune Business Insights.This growth is driven by a shrinking base of arable farmland, a tighter supply of traditional agricultural inputs, a rapid emergence of regenerative ag practices leading to willingness by farmers to adopt new systems that can result in higher yields while being environmentally safe, and consumer sentiment calling for cleaner supply chains and less agrochemical usage. Our teams strong work positions us for growth and continuous discovery of the capability Pink Performance delivers in the field. Global AgInvesting and HighQuest Partners are not a fiduciary in any manner, and the reader assumes the sole responsibility of evaluating the merits and risks associated with the use of any information or other content on this site.